Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide
Status:
Recruiting
Trial end date:
2024-07-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of ixazomib, oral
dexamethasone and in patients with relapsed multiple myeloma who have received lenalidomide.
Phase:
Phase 4
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Beijing Chao Yang Hospital Beijing Hospital Beijing Jishuitan Hospital First Hospital of China Medical University Peking University Third Hospital Second Hospital of Shanxi Medical University The First Affiliated Hospital of Anhui Medical University The First Affiliated Hospital of Dalian Medical University The First Affiliated Hospital of Zhengzhou University The Second Affiliated Hospital of Harbin Medical University Tianjin Medical University Cancer Institute and Hospital Tianjin Medical University General Hospital